What Is a Dangerous A1C Level? Warning Signs to Know

There is an important distinction hiding inside this question, and getting it right could matter a great deal.

A1C is a three-month average. It tells you about your cumulative risk of long-term complications: eye, kidney, nerve, and cardiovascular damage. A high A1C is dangerous over years, not over hours.

Acute danger is different. The hyperglycemic emergencies that send people to hospital, diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), are driven by your current blood glucose, and DKA can develop within hours. Your A1C will not warn you about these. Symptoms will.

So this article answers both questions separately, because conflating them is genuinely risky.

On the long-term side, the evidence is clear and motivating: in the landmark DCCT trial, people managed to an A1C around 7% had roughly 50% fewer microvascular complications than those around 9% (ADA Standards of Care, 2026). Roughly, each 1% reduction in A1C is associated with about a 35% reduction in microvascular complications.

On the acute side, the number to memorise is this: a blood glucose of 300 mg/dL or above that will not come down, or any high reading with vomiting, fruity breath, or confusion, means emergency care now (CDC, 2025).

What you will learn:

• What A1C measures, and the ranges that matter
• Whether there is genuinely a “dangerous” A1C number
• The acute warning signs that require emergency care
• How DKA and HHS differ, and who gets which
• When A1C gives a misleading result

What A1C Actually Measures

A1C, or haemoglobin A1c, measures the percentage of your haemoglobin that has glucose attached to it. Because red blood cells live about three months, A1C reflects your average blood glucose over roughly the previous two to three months.

That averaging is both its strength and its limitation.

• The strength: it is not affected by what you ate this morning, so it gives a stable picture of overall control and predicts long-term complication risk well.
• The limitation: an average conceals extremes. Someone whose glucose swings between very high and very low can produce the same A1C as someone whose glucose stays steady in a moderate range, despite those two situations being quite different. This is one reason continuous glucose monitoring and “time in range” have become important alongside A1C.
• The critical point for this article: A1C cannot tell you whether you are in acute danger right now. It is a rear-view mirror, not a windscreen.

The A1C Ranges

Two things deserve explanation.

• Why “below 7%” rather than “as low as possible”: the relationship between A1C and complications is curvilinear. The biggest gains come from moving someone from very poor control to fair or good control. Going from 7% to 6% offers further benefit, but the absolute gain shrinks while the risk of dangerous low blood sugar rises.
• Why some people have higher targets: the ADA explicitly notes that less stringent targets, up to around 8%, may be appropriate where the benefits of intensive control may not be realised, or where the risks and burdens outweigh the benefits. This includes some older adults, people with limited life expectancy, extensive other conditions, or a history of severe hypoglycemia. A target of 8% is not failure. For the right person, it is correct medicine.

So Is There a “Dangerous” A1C?

Here is the honest answer: clinical guidelines do not define a specific “dangerous” A1C threshold. They define targets, not danger lines. A1C describes accumulating risk on a continuous scale rather than a cliff edge you fall off at a particular number.

That said, some practical benchmarks are meaningful:

• Above 9% is generally regarded as poor control carrying substantially elevated complication risk, and typically prompts a change in treatment. In the DCCT, this was roughly the level of the comparison group that experienced far more complications.
• Above 10% indicates persistently very high average glucose and warrants prompt medical review.
• Any A1C above your individual target, sustained over time, is worth acting on.

But here is what that number cannot do. An A1C of 12% does not mean you are about to collapse, and an A1C of 7.5% does not mean you are safe from a hyperglycemic emergency this week. Someone with a moderate A1C who develops an infection, misses insulin doses, or becomes dehydrated can go into DKA in a matter of hours.

The danger you can plan around is measured in A1C. The danger you must react to is measured in symptoms and current glucose readings.

What the Numbers Mean for Long-Term Risk

The evidence here is unusually strong and worth knowing, because it makes the case for action concrete.

The DCCT compared intensive management (mean A1C about 7.3%) with conventional treatment (mean A1C about 9.1%) in type 1 diabetes. Over six years, the intensive group had roughly 50% fewer microvascular complications, meaning damage to the eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy). Some analyses put the range of reduction at 50 to 76% across different complications.

The UKPDS did something similar in type 2 diabetes, comparing a mean A1C of 7.0% with 7.9%, and found a 25% reduction in microvascular complications from that smaller difference.

A useful rule of thumb: roughly each 1 percentage point reduction in A1C is associated with about a 35% reduction in microvascular complications.

The legacy effect. Both trials found something remarkable in long-term follow-up. Participants who achieved good control early retained benefits for decades afterwards, even after the difference between the groups had disappeared. In the DCCT follow-up study, the group originally managed intensively had a 57% reduction in the risk of non-fatal heart attack, stroke, or cardiovascular death years later.

This is sometimes called metabolic memory, and it carries a genuinely encouraging implication: improving your control now produces benefits that persist even if your numbers drift later. Early action pays a long dividend.

The Acute Warning Signs Doctors Never Ignore

This is the part to read carefully, and the part worth remembering.

General High Blood Sugar Symptoms

These indicate hyperglycemia that needs attention, though not necessarily emergency care:

• Excessive thirst and a dry mouth
• Frequent urination, including waking at night
• Fatigue and weakness
• Blurred vision
• Headache
• Unexplained weight loss

Diabetic Ketoacidosis (DKA): The Emergency Signs

DKA happens when the body lacks enough insulin to use glucose, so it burns fat instead and produces acidic ketones. It is most common in type 1 diabetes but can occur in type 2 and gestational diabetes, and it can develop within hours.

Blood glucose is typically above 250 mg/dL, often in the 350 to 800 range.

Go to the emergency room or call emergency services if:

• Your blood glucose stays at 300 mg/dL or above
• Your breath smells fruity or of acetone
• You are vomiting and cannot keep fluids down
• You have deep, rapid breathing or trouble breathing
• You have severe abdominal pain
• You are confused or unusually drowsy

A dangerous detail worth knowing: DKA frequently masquerades as food poisoning or a stomach bug. Nausea, vomiting, and abdominal pain feel like a viral illness, which is exactly why people delay seeking care. If you have diabetes and a “stomach bug” alongside high glucose readings, treat it as potential DKA until proven otherwise.

Check ketones if you are unwell or your glucose is 250 mg/dL or above, using urine strips or a blood ketone meter, both available over the counter. Elevated ketones with high glucose is a warning sign.

Hyperosmolar Hyperglycemic State (HHS): The Slower Emergency

HHS is mainly seen in type 2 diabetes and develops over days rather than hours, which is part of what makes it dangerous. Extremely high glucose causes massive fluid loss through urination, leading to severe dehydration and dangerously concentrated blood.

Blood glucose is usually above 600 mg/dL.

Call emergency services if you have diabetes and:

• A blood glucose reading over 600 mg/dL
• Confusion or disorientation
• Changes in vision, including sudden loss of vision
• Weakness or paralysis in any part of the body, particularly on one side
• Hallucinations, seeing things that are not there
• Signs of severe dehydration: very dry mouth, sunken eyes, minimal urination

Because HHS builds gradually, it is often missed until the person becomes severely disoriented or loses consciousness. If an older relative with type 2 diabetes becomes confused over several days, high blood sugar is a possibility worth raising urgently.

DKA vs HHS at a Glance

Both are life-threatening, and both require emergency treatment. Do not attempt to manage either at home.

When A1C Gives a Misleading Result

A1C is reliable for most people, but several conditions distort it, and this is worth knowing if your result does not match how you feel or what your glucose meter shows.

A1C can read falsely LOW with:

• Anaemia from blood loss or haemolysis, where red cells are replaced faster
• Recent blood transfusion
• Pregnancy
• Certain haemoglobin variants
• Some liver and kidney conditions

A1C can read falsely HIGH with:

• Iron deficiency anaemia
• Vitamin B12 deficiency
• Some kidney disease
• Certain haemoglobin variants

If you have any of these, or if your A1C consistently disagrees with your home glucose readings, mention it. Your doctor may use alternative measures such as fructosamine, or rely more heavily on continuous glucose monitoring data.

A note on ethnicity: some haemoglobin variants are more common in people of African, Mediterranean, or Southeast Asian ancestry, and can interfere with certain A1C assays. If your results seem inconsistent, this is a reasonable thing to raise.

Beyond A1C: Time in Range

Because A1C hides variability, many clinicians now also use time in range, the percentage of time your glucose stays within a target band, usually 70 to 180 mg/dL, measured by a continuous glucose monitor.

Two people can share an A1C of 7.5% while one spends most of the day in range and the other swings between 50 and 300. The second person faces different risks, including dangerous lows, that A1C alone will not reveal.

If you have access to continuous glucose monitoring, time in range is a valuable companion measure. It does not replace A1C, but it fills in what the average leaves out.

Myths vs. Facts

Common Mistakes to Avoid

1. Treating A1C as a safety signal for today. It cannot detect an emerging emergency.
2. Dismissing vomiting as a stomach bug. With diabetes and high glucose, consider DKA.
3. Waiting to see if a very high reading comes down. At 300 mg/dL and rising, or with symptoms, seek care.
4. Not owning ketone strips. They are cheap, available over the counter, and genuinely useful.
5. Adjusting insulin doses yourself during illness without a sick-day plan agreed with your doctor.
6. Assuming a “good” A1C rules out dangerous swings. Ask about time in range.
7. Accepting an A1C that conflicts with your meter without raising it.

When to See a Doctor

Call emergency services or go to the emergency department immediately if you have:

• Blood glucose at or above 300 mg/dL that will not come down
• Any high reading with vomiting you cannot control
• Fruity or acetone-smelling breath
• Deep, rapid breathing or difficulty breathing
• Severe abdominal pain
• Confusion, disorientation, drowsiness, or hallucinations
• Blood glucose above 600 mg/dL
• Sudden vision changes or one-sided weakness

Book an appointment promptly if you:

• Have an A1C above your agreed target, particularly above 9%
• Have persistent thirst, frequent urination, fatigue, or blurred vision
• Have never discussed a sick-day plan for managing glucose during illness
• Have an A1C that conflicts with your home readings
• Have not had an A1C test in the past six months and have diabetes

A note on sick days: illness raises blood glucose and is one of the most common triggers for DKA. If you have diabetes and have never been given a written sick-day plan covering when to check ketones, how to manage medication, and when to seek help, ask for one. It is one of the most valuable things you can have and one of the most commonly missing.

Action Steps

1. Find out your most recent A1C figure and the target agreed with your doctor.
2. If it is above 9%, book an appointment to discuss treatment intensification.
3. Buy ketone test strips if you use insulin or have type 1 diabetes.
4. Memorise the emergency thresholds: 300 mg/dL persistent, or 600 mg/dL at any point.
5. Learn the DKA signs, especially fruity breath, vomiting, and deep rapid breathing.
6. Ask your doctor for a written sick-day plan.
7. If you use a continuous glucose monitor, ask about your time in range alongside A1C.

Frequently Asked Questions

1. What is a dangerous level of A1C?

Clinical guidelines do not define a specific danger threshold, because A1C reflects accumulating risk on a continuous scale. As a practical benchmark, above 9% is considered poor control with substantially elevated complication risk, and above 10% warrants prompt review. But A1C cannot indicate acute danger; that is signalled by current glucose readings and symptoms.

2. What A1C should I aim for?

Below 7% is the general target for most non-pregnant adults with diabetes. Some people have appropriately higher targets, up to around 8%, including some older adults and those with other significant conditions or a history of severe low blood sugar. Your target should be agreed individually.

3. Can a high A1C cause an emergency?

Not directly. Hyperglycemic emergencies are driven by current glucose, not your three-month average. Someone with a moderate A1C can develop DKA within hours during illness, and someone with a high A1C may feel relatively well day to day.

4. What blood sugar level is a medical emergency?

Seek emergency care if your glucose stays at 300 mg/dL or above, or if you have any high reading with vomiting, fruity breath, deep rapid breathing, severe abdominal pain, or confusion. A reading above 600 mg/dL requires emergency care immediately.

5. What is the difference between DKA and HHS?

DKA is more common in type 1 diabetes, develops within hours, typically involves glucose above 250 mg/dL, and produces ketones, fruity breath, and vomiting. HHS mainly affects people with type 2 diabetes, develops over days, involves glucose usually above 600 mg/dL, and causes severe dehydration and confusion without significant ketones.

Key Takeaways

• A1C is a three-month average that predicts long-term complication risk; it cannot detect acute danger.
• Guidelines set targets rather than danger thresholds, but above 9% signals substantially elevated risk and above 10% warrants prompt review.
• Below 7% is the general target for most adults with diabetes, with higher individualised targets appropriate for some.
• In the DCCT, an A1C around 7% versus around 9% meant roughly 50% fewer microvascular complications.
• Roughly each 1% reduction in A1C is associated with about a 35% reduction in microvascular complications.
• Acute emergencies are signalled by current glucose: 300 mg/dL persistent, or above 600 mg/dL, plus symptoms.
• DKA develops in hours with fruity breath, vomiting, and rapid breathing; HHS develops over days with severe confusion and dehydration.

The Bottom Line

The question “what is a dangerous A1C?” has a more useful answer than a single number, and the distinction matters.

Your A1C tells you about risk accumulating quietly over years. Above 9% is a clear signal to act, and the evidence for acting is strong: bringing a high A1C down meaningfully reduces the eye, kidney, and nerve damage that diabetes causes, and thanks to the legacy effect, that benefit persists for decades. There is no number so high that improvement stops being worthwhile.

But your A1C will not tell you when you are in trouble today. That job belongs to symptoms and to your glucose meter. Learn the signs that doctors treat as emergencies: glucose that stays at 300 mg/dL or above, fruity breath, vomiting you cannot control, deep rapid breathing, and any confusion. Above 600 mg/dL is an emergency at any time. And if you have diabetes and come down with what feels like a stomach bug, take it seriously, because that is exactly how DKA disguises itself.

Know your A1C, agree a target with your doctor, and ask for a written sick-day plan. Those three things cover both the slow risk and the fast one.

Also Read | Teen Anxiety Warning Signs in 2026 Every Parent Needs to Know

References

American Diabetes Association Professional Practice Committee. (2026). 9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes 2026. Diabetes Care, 49(Supplement 1), S183. https://diabetesjournals.org/care/article/49/Supplement_1/S183/163934/

American Diabetes Association Professional Practice Committee. (2025). 6. Glycemic goals and hypoglycemia: Standards of Care in Diabetes 2025. Diabetes Care, 48(Supplement 1), S128. https://diabetesjournals.org/care/article/48/Supplement_1/S128/157561/

Centers for Disease Control and Prevention. (2025). Diabetic ketoacidosis. https://www.cdc.gov/diabetes/about/diabetic-ketoacidosis.html

Cleveland Clinic. (2025). Hyperosmolar hyperglycemic state (HHS). https://my.clevelandclinic.org/health/diseases/21147-hyperosmolar-hyperglycemic-state

Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977–986. https://doi.org/10.1056/NEJM199309303291401

Mayo Clinic. (2025). Diabetic coma: Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/diabetic-coma/symptoms-causes/syc-20371475

National Center for Biotechnology Information. (2025). Hyperglycemic crises. In Endotext. https://www.ncbi.nlm.nih.gov/books/NBK279052/

Stratton, I. M., Adler, A. I., Neil, H. A., Matthews, D. R., Manley, S. E., Cull, C. A., Hadden, D., Turner, R. C., & Holman, R. R. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ, 321(7258), 405–412. https://doi.org/10.1136/bmj.321.7258.405

UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352(9131), 837–853.